Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a winner of Fast Company’s 2025 ...
About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...
The FDA approved the first at-home test for cervical cancer screening, developed by Teal Health. In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening ...
New Delhi: The most powerful weapon against cancer is not always a breakthrough drug; it is often a basic screening test done at the right time. Therefore, for millions of patients worldwide, the ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results